Chinese General Practice ›› 2022, Vol. 25 ›› Issue (32): 4085-4090.DOI: 10.12114/j.issn.1007-9572.2022.0382
• Article·Epidemiologic Research • Previous Articles Next Articles
Received:
2022-04-29
Revised:
2022-08-01
Published:
2022-11-15
Online:
2022-08-18
Contact:
LIU Gang
About author:
通讯作者:
刘刚
作者简介:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0382
时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类慢性病合计 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 占总死亡人数比例(%) | |
2014 | 46.79 | 77.22 | 1.26 | 2.57 | 25.34 | 44.40 | 1.94 | 3.57 | 75.33 | 127.76 | 77.20 |
2015 | 58.80 | 96.39 | 1.98 | 4.19 | 27.87 | 48.85 | 1.23 | 2.31 | 89.89 | 151.74 | 76.58 |
2016 | 52.71 | 89.16 | 3.38 | 6.40 | 24.87 | 41.88 | 2.78 | 5.11 | 83.73 | 142.55 | 79.35 |
2017 | 50.45 | 84.89 | 2.10 | 4.02 | 21.35 | 35.69 | 1.48 | 2.82 | 75.38 | 127.41 | 82.63 |
2018 | 50.51 | 87.20 | 2.15 | 3.95 | 21.84 | 37.27 | 1.93 | 3.55 | 76.43 | 131.98 | 82.01 |
2019 | 44.77 | 78.60 | 1.98 | 3.71 | 19.73 | 34.22 | 1.83 | 3.47 | 68.31 | 120.00 | 82.03 |
2020 | 47.38 | 82.16 | 2.07 | 4.01 | 21.34 | 37.67 | 1.49 | 2.90 | 72.28 | 126.74 | 81.81 |
APC(%) | -1.90 | -0.90 | 3.80 | 2.20 | -4.70 | -4.60 | -1.30 | -0.60 | -2.70 | -2.00 | 1.20 |
Z值 | -1.20 | -0.60 | 0.70 | 0.40 | -3.50 | -2.90 | -0.20 | -0.10 | -1.90 | -1.50 | 3.50 |
P值 | 0.290 | 0.600 | 0.540 | 0.710 | 0.017 | 0.032 | 0.821 | 0.909 | 0.119 | 0.201 | 0.020 |
Table 1 Yearly crude mortality rates and temporal trends of four major noncommunicable diseases among Shenzhen permanent residents aged 30-69 from 2014 to 2020
时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类慢性病合计 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 占总死亡人数比例(%) | |
2014 | 46.79 | 77.22 | 1.26 | 2.57 | 25.34 | 44.40 | 1.94 | 3.57 | 75.33 | 127.76 | 77.20 |
2015 | 58.80 | 96.39 | 1.98 | 4.19 | 27.87 | 48.85 | 1.23 | 2.31 | 89.89 | 151.74 | 76.58 |
2016 | 52.71 | 89.16 | 3.38 | 6.40 | 24.87 | 41.88 | 2.78 | 5.11 | 83.73 | 142.55 | 79.35 |
2017 | 50.45 | 84.89 | 2.10 | 4.02 | 21.35 | 35.69 | 1.48 | 2.82 | 75.38 | 127.41 | 82.63 |
2018 | 50.51 | 87.20 | 2.15 | 3.95 | 21.84 | 37.27 | 1.93 | 3.55 | 76.43 | 131.98 | 82.01 |
2019 | 44.77 | 78.60 | 1.98 | 3.71 | 19.73 | 34.22 | 1.83 | 3.47 | 68.31 | 120.00 | 82.03 |
2020 | 47.38 | 82.16 | 2.07 | 4.01 | 21.34 | 37.67 | 1.49 | 2.90 | 72.28 | 126.74 | 81.81 |
APC(%) | -1.90 | -0.90 | 3.80 | 2.20 | -4.70 | -4.60 | -1.30 | -0.60 | -2.70 | -2.00 | 1.20 |
Z值 | -1.20 | -0.60 | 0.70 | 0.40 | -3.50 | -2.90 | -0.20 | -0.10 | -1.90 | -1.50 | 3.50 |
P值 | 0.290 | 0.600 | 0.540 | 0.710 | 0.017 | 0.032 | 0.821 | 0.909 | 0.119 | 0.201 | 0.020 |
时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | ||||
---|---|---|---|---|---|---|---|---|
死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | |
2014 | 54.28 | 95.52 | 0.44 | 0.85 | 35.41 | 63.23 | 2.55 | 5.00 |
2015 | 73.44 | 73.44 | 0.93 | 1.80 | 42.69 | 76.46 | 1.77 | 3.57 |
2016 | 59.06 | 59.06 | 4.62 | 8.85 | 37.32 | 63.48 | 3.85 | 7.19 |
2017 | 56.48 | 101.69 | 2.34 | 4.51 | 32.27 | 53.50 | 2.26 | 4.43 |
2018 | 57.16 | 103.73 | 3.00 | 5.51 | 31.75 | 54.28 | 3.17 | 5.90 |
2019 | 50.18 | 93.51 | 2.69 | 4.97 | 29.09 | 50.42 | 2.69 | 5.41 |
2020 | 57.23 | 106.03 | 3.44 | 6.71 | 35.29 | 62.34 | 2.46 | 5.08 |
APC(%) | -2.20 | 5.00 | 32.40 | 31.90 | -3.30 | -3.60 | 1.90 | 2.50 |
Z值 | -1.00 | 1.20 | 2.40 | 2.40 | -1.60 | -1.50 | 0.40 | 0.60 |
P值 | 0.350 | 0.270 | 0.060 | 0.070 | 0.171 | 0.187 | 0.720 | 0.606 |
Table 2 Yearly crude mortality rates and temporal trends of four major noncommunicable diseases among Shenzhen male permanent residents aged 30-69 from 2014 to 2020
时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | ||||
---|---|---|---|---|---|---|---|---|
死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | |
2014 | 54.28 | 95.52 | 0.44 | 0.85 | 35.41 | 63.23 | 2.55 | 5.00 |
2015 | 73.44 | 73.44 | 0.93 | 1.80 | 42.69 | 76.46 | 1.77 | 3.57 |
2016 | 59.06 | 59.06 | 4.62 | 8.85 | 37.32 | 63.48 | 3.85 | 7.19 |
2017 | 56.48 | 101.69 | 2.34 | 4.51 | 32.27 | 53.50 | 2.26 | 4.43 |
2018 | 57.16 | 103.73 | 3.00 | 5.51 | 31.75 | 54.28 | 3.17 | 5.90 |
2019 | 50.18 | 93.51 | 2.69 | 4.97 | 29.09 | 50.42 | 2.69 | 5.41 |
2020 | 57.23 | 106.03 | 3.44 | 6.71 | 35.29 | 62.34 | 2.46 | 5.08 |
APC(%) | -2.20 | 5.00 | 32.40 | 31.90 | -3.30 | -3.60 | 1.90 | 2.50 |
Z值 | -1.00 | 1.20 | 2.40 | 2.40 | -1.60 | -1.50 | 0.40 | 0.60 |
P值 | 0.350 | 0.270 | 0.060 | 0.070 | 0.171 | 0.187 | 0.720 | 0.606 |
时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | ||||
---|---|---|---|---|---|---|---|---|
死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | |
2014 | 38.82 | 44.45 | 2.12 | 4.21 | 14.63 | 25.25 | 1.30 | 2.23 |
2015 | 43.20 | 65.76 | 3.10 | 6.42 | 12.07 | 20.56 | 0.66 | 1.07 |
2016 | 45.95 | 72.24 | 2.05 | 3.89 | 11.59 | 19.70 | 1.64 | 3.08 |
2017 | 44.02 | 69.05 | 1.85 | 3.46 | 9.71 | 17.16 | 0.65 | 1.21 |
2018 | 43.42 | 70.85 | 1.24 | 2.34 | 11.28 | 19.74 | 0.62 | 0.05 |
2019 | 39.01 | 64.26 | 1.23 | 2.42 | 9.75 | 17.40 | 0.90 | 1.55 |
2020 | 38.38 | 61.94 | 0.82 | 1.68 | 8.60 | 15.64 | 0.60 | 1.02 |
APC(%) | -1.00 | 3.40 | -17.00 | -17.00 | -7.10 | -6.10 | -9.10 | -18.50 |
Z值 | -0.70 | 1.10 | -4.80 | -4.70 | -4.70 | -4.10 | -1.30 | -0.80 |
P值 | 0.490 | 0.330 | 0.010 | 0.006 | 0.005 | 0.010 | 0.240 | 0.477 |
Table 3 Yearly crude mortality rates and temporal trends of four major noncommunicable diseases among Shenzhen female permanent residents aged 30-69 from 2014 to 2020
时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | ||||
---|---|---|---|---|---|---|---|---|
死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | |
2014 | 38.82 | 44.45 | 2.12 | 4.21 | 14.63 | 25.25 | 1.30 | 2.23 |
2015 | 43.20 | 65.76 | 3.10 | 6.42 | 12.07 | 20.56 | 0.66 | 1.07 |
2016 | 45.95 | 72.24 | 2.05 | 3.89 | 11.59 | 19.70 | 1.64 | 3.08 |
2017 | 44.02 | 69.05 | 1.85 | 3.46 | 9.71 | 17.16 | 0.65 | 1.21 |
2018 | 43.42 | 70.85 | 1.24 | 2.34 | 11.28 | 19.74 | 0.62 | 0.05 |
2019 | 39.01 | 64.26 | 1.23 | 2.42 | 9.75 | 17.40 | 0.90 | 1.55 |
2020 | 38.38 | 61.94 | 0.82 | 1.68 | 8.60 | 15.64 | 0.60 | 1.02 |
APC(%) | -1.00 | 3.40 | -17.00 | -17.00 | -7.10 | -6.10 | -9.10 | -18.50 |
Z值 | -0.70 | 1.10 | -4.80 | -4.70 | -4.70 | -4.10 | -1.30 | -0.80 |
P值 | 0.490 | 0.330 | 0.010 | 0.006 | 0.005 | 0.010 | 0.240 | 0.477 |
时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类慢性病合计 | |||||
---|---|---|---|---|---|---|---|---|---|---|
死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | |
2014 | 818 | 6.50 | 22 | 0.26 | 443 | 3.89 | 34 | 0.31 | 1 317 | 10.73 |
2015 | 1 097 | 7.80 | 37 | 0.43 | 520 | 4.29 | 23 | 0.23 | 1 677 | 12.45 |
2016 | 1 062 | 7.56 | 68 | 0.59 | 501 | 3.67 | 56 | 0.46 | 1 687 | 12.00 |
2017 | 1 127 | 7.21 | 47 | 0.37 | 477 | 3.12 | 33 | 0.28 | 1 684 | 10.77 |
2018 | 1 175 | 7.49 | 50 | 0.33 | 508 | 3.20 | 45 | 0.35 | 1 778 | 11.15 |
2019 | 1 128 | 6.74 | 50 | 0.33 | 497 | 2.96 | 46 | 0.33 | 1 721 | 10.17 |
2020 | 1 212 | 6.82 | 53 | 0.37 | 546 | 3.19 | 38 | 0.30 | 1 849 | 10.47 |
APC(%) | -0.60 | 0.10 | -5.10 | 1.40 | -1.90 | |||||
Z值 | -0.40 | 0.00 | -3.40 | 0.30 | -1.60 | |||||
P值 | 0.697 | 0.991 | 0.019 | 0.772 | 0.171 |
Table 4 Yearly probability of premature death from four major noncommunicable diseases and temporal trends among Shenzhen permanent residents aged 30-69 from 2014 to 2020
时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类慢性病合计 | |||||
---|---|---|---|---|---|---|---|---|---|---|
死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | |
2014 | 818 | 6.50 | 22 | 0.26 | 443 | 3.89 | 34 | 0.31 | 1 317 | 10.73 |
2015 | 1 097 | 7.80 | 37 | 0.43 | 520 | 4.29 | 23 | 0.23 | 1 677 | 12.45 |
2016 | 1 062 | 7.56 | 68 | 0.59 | 501 | 3.67 | 56 | 0.46 | 1 687 | 12.00 |
2017 | 1 127 | 7.21 | 47 | 0.37 | 477 | 3.12 | 33 | 0.28 | 1 684 | 10.77 |
2018 | 1 175 | 7.49 | 50 | 0.33 | 508 | 3.20 | 45 | 0.35 | 1 778 | 11.15 |
2019 | 1 128 | 6.74 | 50 | 0.33 | 497 | 2.96 | 46 | 0.33 | 1 721 | 10.17 |
2020 | 1 212 | 6.82 | 53 | 0.37 | 546 | 3.19 | 38 | 0.30 | 1 849 | 10.47 |
APC(%) | -0.60 | 0.10 | -5.10 | 1.40 | -1.90 | |||||
Z值 | -0.40 | 0.00 | -3.40 | 0.30 | -1.60 | |||||
P值 | 0.697 | 0.991 | 0.019 | 0.772 | 0.171 |
时间(年) | 男性 | 女性 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类主要慢性病合计 | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类主要慢性病合计 | |
2014 | 8.30 | 0.06 | 5.56 | 0.46 | 13.94 | 4.76 | 0.44 | 2.22 | 0.18 | 7.50 |
2015 | 10.60 | 0.14 | 6.69 | 0.36 | 17.09 | 5.05 | 0.69 | 1.87 | 0.09 | 7.59 |
2016 | 9.35 | 0.81 | 5.54 | 0.71 | 15.16 | 5.86 | 0.38 | 1.78 | 0.23 | 8.13 |
2017 | 8.87 | 0.40 | 4.66 | 0.45 | 13.64 | 5.65 | 0.32 | 1.57 | 0.12 | 7.58 |
2018 | 9.11 | 0.45 | 4.63 | 0.55 | 13.94 | 5.92 | 0.21 | 1.77 | 0.15 | 7.95 |
2019 | 8.29 | 0.45 | 4.27 | 0.52 | 12.78 | 5.28 | 0.21 | 1.63 | 0.15 | 7.19 |
2020 | 9.08 | 0.61 | 5.18 | 0.52 | 14.37 | 4.93 | 0.17 | 1.45 | 0.11 | 6.59 |
APC(%) | -0.90 | 38.00 | -4.50 | 3.20 | -2.00 | 0.70 | -18.70 | -5.40 | -3.50 | -1.80 |
Z值 | -0.50 | 2.40 | -2.00 | 0.80 | -1.20 | 0.40 | -4.80 | -4.10 | -0.60 | -1.60 |
P值 | 0.618 | 0.060 | 0.107 | 0.472 | 0.277 | 0.695 | 0.005 | 0.010 | 0.575 | 0.170 |
Table 5 Sex-based analysis of yearly probability of premature death from four major noncommunicable diseases and temporal trends among Shenzhen permanent residents aged 30-69 from 2014 to 2020
时间(年) | 男性 | 女性 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类主要慢性病合计 | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类主要慢性病合计 | |
2014 | 8.30 | 0.06 | 5.56 | 0.46 | 13.94 | 4.76 | 0.44 | 2.22 | 0.18 | 7.50 |
2015 | 10.60 | 0.14 | 6.69 | 0.36 | 17.09 | 5.05 | 0.69 | 1.87 | 0.09 | 7.59 |
2016 | 9.35 | 0.81 | 5.54 | 0.71 | 15.16 | 5.86 | 0.38 | 1.78 | 0.23 | 8.13 |
2017 | 8.87 | 0.40 | 4.66 | 0.45 | 13.64 | 5.65 | 0.32 | 1.57 | 0.12 | 7.58 |
2018 | 9.11 | 0.45 | 4.63 | 0.55 | 13.94 | 5.92 | 0.21 | 1.77 | 0.15 | 7.95 |
2019 | 8.29 | 0.45 | 4.27 | 0.52 | 12.78 | 5.28 | 0.21 | 1.63 | 0.15 | 7.19 |
2020 | 9.08 | 0.61 | 5.18 | 0.52 | 14.37 | 4.93 | 0.17 | 1.45 | 0.11 | 6.59 |
APC(%) | -0.90 | 38.00 | -4.50 | 3.20 | -2.00 | 0.70 | -18.70 | -5.40 | -3.50 | -1.80 |
Z值 | -0.50 | 2.40 | -2.00 | 0.80 | -1.20 | 0.40 | -4.80 | -4.10 | -0.60 | -1.60 |
P值 | 0.618 | 0.060 | 0.107 | 0.472 | 0.277 | 0.695 | 0.005 | 0.010 | 0.575 | 0.170 |
[1] |
|
[2] |
健康中国行动推进委员会. 健康中国行动(2019—2030年)[EB/OL]. [2022-06-26].
|
[3] |
深圳市政协.健康深圳行动计划(2017-2020年)[EB/OL]. [2022-06-26].
|
[4] |
王玲,陈伟文,张彩娟,等. 2015—2019年深圳市坪山区重要慢性病早死概率和去死因期望寿命分析[J]. 职业与健康,2021,37(9):1223-1227. DOI:10.13329/j.cnki.zyyjk.2021.0309.
|
[5] |
|
[6] |
|
[7] |
徐继英,李新建,姚海宏,等. 上海市成年人慢性病相关危险因素行为特征研究[J]. 中华预防医学杂志,2013,47(9):821-825. DOI:10.3760/cma.j.issn.0253-9624.2013.09.011.
|
[8] |
靳雅男,杨艺,谢帆,等. 2012—2016年宁夏心脑血管疾病死亡状况分析[J]. 中国慢性病预防与控制,2019,27(11):806-808,813. DOI:10.16386/j.cjpccd.issn.1004-6194.2019.11.002.
|
[9] |
雷智,张燕,刘霞,等. 四川省泸州市2017年心脑血管疾病死亡特征及疾病负担分析[J]. 现代预防医学,2019,46(18):3373-3376.
|
[10] |
陈亦晨,陈华,周弋,等. 2002—2020年上海市浦东新区居民主要慢性病早死概率研究[J]. 中国全科医学,2022,25(9):1098-1104. DOI:10.12114/j.issn.1007-9572.2021.02.074.
|
[11] |
杨梨丽,林启,王玉超,等. 2009—2018年舟山市4类主要慢性病早死概率及"健康中国2030"目标分析[J]. 中国慢性病预防与控制,2021,29(2):140-143. DOI:10.16386/j.cjpccd.issn.1004-6194.2021.02.014.
|
[12] |
刘倩云,钟定威,马敏杰,等. 2015—2019年中山市城区居民主要慢性病早死概率变化分析[J]. 中国公共卫生管理,2021,37(6):803-806. DOI:10.19568/j.cnki.23-1318.2021.06.0025.
|
[13] |
吕丽娜,陈楠. 2010—2017年天津市河东区主要慢性病早死率及其变化趋势[J]. 中国慢性病预防与控制,2020,28(1):74-77. DOI:10.16386/j.cjpccd.issn.1004-6194.2020.01.019.
|
[14] |
陈娜,邓静,雷群建,等. 2011—2019年重庆市长寿区4类主要慢性病早死概率及变化趋势[J]. 保健医学研究与实践,2021,18(5):30-34.
|
[15] |
陈培培,俞浩,娄培安,等. 2015—2019年徐州市主要慢性病过早死亡情况及变化趋势[J]. 中国慢性病预防与控制,2022,30(1):77-80. DOI:10.16386/j.cjpccd.issn.1004-6194.2022.01.019.
|
[16] |
国务院办公厅. 国务院办公厅关于印发中国防治慢性病中长期规划(2017—2025年)的通知[EB/OL]. [2022-03-17].
|
[17] |
丁贤彬,唐文革,焦艳,等. 2010—2016年重庆市4种主要慢性病早死率及其变化趋势[J]. 中国慢性病预防与控制,2017,25(9):641-645. DOI:10.16386/j.cjpccd.issn.1004-6194.2017.09.001.
|
[18] |
孙晓凯,刘付东,梁季,等. 2008—2017年盐城市主要慢性病死亡情况及其变化趋势分析[J]. 中国慢性病预防与控制,2019,27(4):314-317. DOI:10.16386/j.cjpccd.issn.1004-6194.2019.04.019.
|
[19] |
刘辉,丛革新,贾鑫. 2009—2018年天津市河北区主要慢性病过早死亡情况及其趋势分析[J]. 中国慢性病预防与控制,2021,29(8):639-642. DOI:10.16386/j.cjpccd.issn.1004-6194.2021.08.019.
|
[1] | LI Dianjiang, PAN Enchun, SUN Zhongming, WEN Jinbo, WANG Miaomiao, WU Ming, SHEN Chong. The Current Status and Influencing Factors of Clinical Inertia in Type 2 Diabetes Patients in Community [J]. Chinese General Practice, 2023, 26(34): 4296-4301. |
[2] | LIN Kai, YAO Mi, CHEN Zhang, JI Xinxin, LIN Runqi, CHEN Yongsong, Sim MOIRA. Conceptual Framework and Responding Approach of Treatment Burden of Type 2 Diabetes: a Video Recording-based Analysis [J]. Chinese General Practice, 2023, 26(34): 4302-4307. |
[3] | YANG Hui, HU Ruwei, LIU Ruqing, LU Junfeng, WU Jinglan. Relationship between Community Health Service Experience and Glycemic Control Outcomes in Patients with Diabetes Mellitus [J]. Chinese General Practice, 2023, 26(34): 4290-4295. |
[4] | YU Xinyan, ZHAO Jun, ZHAO Xiaoye, JIANG Qingru, CHEN Yatian, WANG Yan, ZHANG Haicheng. Application of Mobile Smart Healthcare in the Prevention and Control of Cardiovascular Diseases in Elderly Patients with Chronic Diseases in Primary Care [J]. Chinese General Practice, 2023, 26(33): 4167-4172. |
[5] | LI Qianqian, CHEN Xunrui, ZHANG Wenying, YUAN Haihua, ZHANG Yanjie, JIANG Bin, LIU Feng. Demand and Influencing Factors for Community Health Services during Chemotherapy of Patients with Advanced Cancer [J]. Chinese General Practice, 2023, 26(33): 4173-4180. |
[6] | LI Yujing, JIN Yichao, CHEN Xing, JI Mengying, DAI Huihua. Risk Factors for Endometrial Lesions Detected by Hysteroscopy in Breast Cancer Patients Taking Tamoxifen [J]. Chinese General Practice, 2023, 26(32): 4026-4030. |
[7] | ZHANG Juan, LI Haifen, LI Xiaoman, YAO Miao, MA Huizhen, MA Qiang. Construction of Recurrence Risk Prediction Model for Diabetic Foot Ulcer on the Basis of Logistic Regression, Support Vector Machine and BP Neural Network Model [J]. Chinese General Practice, 2023, 26(32): 4013-4019. |
[8] | GAO Dekang, WEI Shaohua, MA Xiaoming, DU Peng, XING Chungen, CAO Chun. Risk Factors for Loss of Skeletal Muscle Mass and Its Correlation with Complications after Major Hepatectomy for Liver Cancer [J]. Chinese General Practice, 2023, 26(32): 4031-4037. |
[9] | ZHANG Jifang, CHEN Fang, TANG Jiawen, LI Hongliang. Predictive Value of Tumor Budding and Tumor-infiltrating Lymphocytes on Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma [J]. Chinese General Practice, 2023, 26(32): 4038-4042. |
[10] | ZHANG Ming, XU Jing, SUN Zhenhua, ZHAO Wenhao, MA Yingqian, ZHANG Jianqiao, SHEN Haiping. Improvement of Nutritional Status of Elderly Patients with Severe Obstruction Esophageal Carcinoma by Image-guided Photodynamic Therapy [J]. Chinese General Practice, 2023, 26(30): 3780-3784. |
[11] | LI Jilei, LI Honglin, XU Yanchao, LIU Yanan, CHEN Mengli, SHAO Shuai, MA Chunzheng. Clinical Study on the Combination of Xiaotan Huayu Tongyi Granules, Channel Kaijie Pills and Chemotherapy in the Treatment of Esophageal Cancer [J]. Chinese General Practice, 2023, 26(30): 3759-3764. |
[12] | ZHENG Yuling, ZHANG Yaling, LIU Huaimin, XU Yanchao, JIA Xiaolin, LI Junsai, HE Wenlong, TONG Xinduo, QIN Shanwen, ZHANG Lihan. Clinical Observation of Dingxiang Guanshitong Hanhua Pills Alone and Its Combination with Fugui Guanshitong Granules in the Treatment of Advanced Esophageal Cancer [J]. Chinese General Practice, 2023, 26(30): 3765-3771. |
[13] | CHENG Jingwei, QIAO Junjun, YIN Zhen, HU Junpeng, WANG Qinghe, LIU Yangqing, WANG Yanfang. Interpretation of ISPAD Clinical Practice Consensus Guidelines 2022: Exercise in Children and Adolescents with Diabetes [J]. Chinese General Practice, 2023, 26(30): 3719-3724. |
[14] | PAN Ye, LIU Zhihui, HU Qianqian, WANG Liuyi. Patterns of Coexistence of Multiple Chronic Conditions among Chinese Elderly [J]. Chinese General Practice, 2023, 26(29): 3608-3615. |
[15] | WANG Xiaoran, ZHANG Dan. Influence of Multimorbidity on Anxiety Symptoms among Chinese Elderly People: a Propensity Score-matched Study [J]. Chinese General Practice, 2023, 26(29): 3622-3627. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||